Chinese Journal of Tissue Engineering Research ›› 2015, Vol. 19 ›› Issue (49): 7908-7913.doi: 10.3969/j.issn.2095-4344.2015.49.007

Previous Articles     Next Articles

Effects of cyclooxygenase inhibitors on nuclear factor κB and CD4+/CD8+ expression in rat models of acute incomplete spinal cord injury 

Xin Zhi-qiang, Pan Meng, Wang Jing-liang, Zheng Quan-xin, Xu Yi-dong, Pi An-ping   

  1. Spine Disease Sickroom, Second Department of Orthopedics, Guangzhou Orthopedic Hospital, Guangzhou 510045, Guangdong Province, China
  • Received:2015-09-21 Online:2015-11-30 Published:2015-11-30
  • About author:Xin Zhi-qiang, Associate chief physician, Spine Disease Sickroom, Second Department of Orthopedics, Guangzhou Orthopedic Hospital, Guangzhou 510045, Guangdong Province, China
  • Supported by:

    Science and Technology Program of Guangdong Province, China, No. 20120309

Abstract:

BACKGROUND: Celecoxib has advantages including fewer adverse reactions and low cost over the commonly used methylprednisolone in the treatment of acute spinal cord injury, but the effective dose cannot be well controlled.
OBJECTIVE: To investigate different doses of cyclooxygenase inhibitors on nuclear factor κB and CD4+/CD8+ expression in rat models of acute incomplete spinal cord injury.
METHODS: Rat models of incomplete spinal cord injury in T8 and T9 segments were established using modified Allen method. Sixty successful modeling rats were randomly and evenly divided into 4 groups: simple injury group and low, medium-and high-dose of celecoxib groups. Rats in simple injury group were not applied any drugs. Rats in low-, medium- and high-dose celecoxib groups were respectively intragastrically administered 25, 50 and 100 mg/kg celecoxib after 30 minutes of spinal cord injury. 
RESULTS AND CONCLUSION: After celecoxib treatment, rat neurological function was significantly improved. Nuclear factor κB expression level in spinal cord was significantly decreased. CD4+ and CD8+ T cell numbers in peripheral blood were significantly decreased. Low dose of celecoxib treatment had a better outcome. These results suggest that different doses of celecoxib can treat acute traumatic spinal cord injury, and low-dose
(25 mg/kg) celecoxib treatment can achieve a better outcome. 
 

CLC Number: